Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of April 29, 2025 • 6:00 AM ET

Date/Time Source News Release
04/14/2025 06:30 AM EDT ACCESS Newswire Measles Outbreak Expands Begging for a Drug to Treat the Infection - NanoViricides Declares it is Ready to Fight the Outbreak
03/11/2025 07:30 AM EDT ACCESS Newswire NanoViricides Not Affected by Tariffs and Other Policies, Has Excellent Long Term Outlook, Stock-Price Decline Misguided, Explains the Company
03/04/2025 06:30 AM EST ACCESS Newswire Measles Outbreak: NV-387 Promises To Be An Effective Drug To Treat Patients; We are Ready To Work With HHS, Says NanoViricides President Dr. Anil Diwan
02/19/2025 06:30 AM EST ACCESS Newswire NanoViricides, Inc. Has Filed its Quarterly Report
02/11/2025 06:30 AM EST ACCESS Newswire NanoViricides Drug Can Fight Bird Flu Pandemic; H5N1 Virus Cannot Escape
01/29/2025 06:30 AM EST ACCESS Newswire NanoViricides to Present at the MicroCap Conference on Wednesday, January 29, 2025
01/27/2025 06:30 AM EST ACCESS Newswire NanoViricides Engages CRO for Phase II Clinical Trial
01/13/2025 06:30 AM EST ACCESSWIRE NanoViricides to Present at the Biotech Showcase in San Fransisco on Tuesday, January 14, 2025
01/08/2025 06:30 AM EST ACCESSWIRE Multiple Viral Threats Amplify Call for Preparedness with Broad-Spectrum Antivirals
12/23/2024 06:30 AM EST ACCESSWIRE NanoViricides is in a Great Position to Fight Potential Bird Flu Pandemic with a Drug that the Mercurial H5N1 Influenza A Virus is Unlikely to Escape
Page

Additional News

As of April 29, 2025 • 6:00 AM ET

Date/Time Source News Release
03/12/2025 04:15 PM EDT Investing News Network Bird Flu Vaccine Stocks: 8 Companies Developing H5N1 Vaccines
03/11/2025 10:35 AM EDT InvestorBrandNetwork InvestorNewsBreaks - NanoViricides (NYSE American: NNVC) Highlights Antiviral Pipeline, Positions Stock as Market Hedge
03/04/2025 08:35 AM EST InvestorBrandNetwork InvestorNewsBreaks - NanoViricides (NYSE American: NNVC) Highlights NV-387 as Potential Measles Treatment Amid Outbreak
02/19/2025 11:43 AM EST InvestorBrandNetwork BioMedNewsBreaks - NanoViricides (NYSE American: NNVC) Reports Financials, Advances NV-387 Antiviral Trials
02/19/2025 06:36 AM EST SeekingAlpha NanoViricides GAAP EPS of -$0.14
02/11/2025 08:30 AM EST InvestorBrandNetwork InvestorNewsBreaks - NanoViricides (NYSE American: NNVC) Claims NV-387 Ready to Combat Bird Flu
01/29/2025 08:30 AM EST InvestorBrandNetwork InvestorNewsBreaks - NanoViricides (NYSE American: NNVC) Showcases NV-387's Broad-Spectrum Antiviral Potential at MicroCap Conference
01/27/2025 08:30 AM EST InvestorBrandNetwork InvestorNewsBreaks - NanoViricides (NYSE American: NNVC) Partners with CRO to Advance NV-387 Antiviral Drug to Phase II Trials
01/13/2025 08:30 AM EST InvestorBrandNetwork InvestorNewsBreaks - NanoViricides (NYSE American: NNVC) to Present Broad-Spectrum Antiviral Innovations at Biotech Showcase 2025
01/08/2025 08:30 AM EST InvestorBrandNetwork InvestorNewsBreaks - NanoViricides (NYSE American: NNVC) Highlights NV-387 as a Broad-Spectrum Antiviral Solution to Emerging Threats
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.